Lisata Therapeutics Inc. (LSTA)

Lisata Therapeutics Inc. (LSTA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $11.2M; returns 1 day -0.9%, 1 week -3.3%, 1 year -57.6%.

Lisata Therapeutics Inc. is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for advanced solid tumors and other serious diseases. Its core technology is the proprietary CendR Platform®, which utilizes the cyclic peptide product candidate certepetide (formerly LSTA1 or CEND-1).

Groups LSTA belongs to

• Biotechnology
• Clinical Stage
• Clinical Stage Biotech
• Pharmaceuticals
• Oncology
• Cancer Therapeutics
• Biopharmaceutical
• Clinical Stage Biopharma
• Life Sciences

LSTA financial model: income statement, cash flow and balance sheet